Russian pharma pipeline dominated by private entities, but no clear source of capital
In the wake of Russia’s invasion of Ukraine, there have been significant financial sanctions on the country, crippling the Russian…
ByIn the wake of Russia’s invasion of Ukraine, there have been significant financial sanctions on the country, crippling the Russian…
ByIs it ethical to sell baby food in Russia in an era of sanctions? Or medicine? This is a dilemma…
ByWestern sanctions may make companies cautious about entering any strategic alliances with or receiving any capital from Russia.
ByOverall venture capital financing from US investors for foreign innovator drugs is almost 500 times that from Russian investors.
ByCertain big pharma companies have reconsidered their clinical trial footprint in Russia in response to the Ukraine invasion. Clinical Trials…
ByThe Ukraine crisis had impacted assessments of the vaccine and the health agency was experiencing operational issues.
The company will donate profits generated from medicine sales in Russia to organisations that provide humanitarian relief.
The company does not anticipate any supply chain disruptions or price pressure due to the Russia-Ukraine crisis.